Abbott Dorsal Column Stimulator Offers Relief from Chronic Back Pain without Abnormal Sensations

The Abbott BurstDR and DISTINCT study have made a significant breakthrough in treating chronic back pain using spinal cord stimulation therapy. This innovative technology delivers mild electrical pulses to the spine, providing relief from pain signals traveling to the brain. Unlike other treatments that may cause abnormal sensations of tingling or paresthesia, Abbott's proprietary BurstDR waveform does not produce these uncomfortable side effects.

Spinal cord stimulation (SCS) therapies feature Abbott's proprietary low-energy BurstDR waveform, which has received expanded FDA indications in the United States. The new indication spans the entirety of Abbott's SCS portfolio, including the recharge-free Proclaim SCS family and the rechargeable Eterna SCS platform.

According to Timothy Deer, president and CEO of the Spine and Nerve Centers of the Virginias in Charleston, West Virginia, 'This new indication for Abbott's SCS devices, together with BurstDR stimulation, allows physicians the ability to identify and treat a new group of people, providing them with relief from chronic back pain.'

The DISTINCT study demonstrated improved pain levels with Abbott's proprietary BurstDR SCS technology. The results showed enhanced ability to perform daily activities and emotional well-being in individuals with chronic back pain. Additionally, the study supported the labeling expansion for the use of Abbott's spinal cord stimulation devices.

The FDA approval applies to the treatment of chronic back pain in those who have not had or are not eligible to receive back surgery. This is also known as non-surgical back pain. With this new indication, more people can now benefit from Abbott's spinal cord stimulation technology and find relief from their chronic back pain.

In conclusion, Abbott's dorsal column stimulator offers a safe and effective treatment option for individuals suffering from chronic back pain without the risk of abnormal sensations or side effects. The expanded FDA indications provide greater access to this innovative therapy, giving more people hope for improved quality of life and reduced suffering from chronic back pain.

Abbott dorsal column stimulator